The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $395,415 in first-year total cost, median $197,708.
Most frequent study sections
- Cancer Biomarkers Study Section[CBSS]1
- Epidemiology of Cancer Study Section[EPIC]1
Most frequent institutions
- EMORY UNIVERSITY1
- UNIVERSITY OF ALABAMA AT BIRMINGHAM1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2014 | A Novel genomics-based approach to differentiate HPV-positive and -negative HNC1R21CA182661-01A1 | CHEN, ZHUO GEORGIASABA, NABIL F | EMORY UNIVERSITY, GA | $203,580 | CBSS |
| 2014 | Microbiome based Approach to Identify the Progression Potential of CIN 2 lesions1R21CA188066-01 | PIYATHILAKE, CHANDRIKA J. | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $191,835 | EPIC |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.